A University-Patented Probiotic Is Now Available as a Consumer Supplement

Provaxus Licenses NC State’s Probiotic for Reducing GI Inflammation

The new probiotic supplement uses an extensively researched strain engineered to reduce gastrointestinal inflammation, giving the product “a very broad audience”.

Provaxus has licensed NCK2025™, a specialized Lactobacillus acidophilus probiotic strain from North Carolina State University designed to reduce gastrointestinal inflammation. The technology leverages decades of research to suppress chronic inflammation and strengthen the gut barrier, with plans to develop the discovery into commercial medical foods or supplements.

You can read the full article at NutraIngredients here.